Evidence map›Paper›PMID 34133429›Full record

ArticlePloS one2021

Extracellular proteolytic activation of Pseudomonas aeruginosa aminopeptidase (PaAP) and insight into the role of its non-catalytic N-terminal domain.

Itschak Axelrad, Mary Safrin, Rivka Cahan, Sang-Jin Suh, Dennis E Ohman, Efrat Kessler

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Secreted Aminopeptidase ofInternational journal of molecular sciences · 2024
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Itschak AxelradMaurice and Gabriela Goldschleger Eye Research Institute, Tel Aviv University Sackler Faculty of Medicine, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
Mary SafrinMaurice and Gabriela Goldschleger Eye Research Institute, Tel Aviv University Sackler Faculty of Medicine, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
Rivka CahanMaurice and Gabriela Goldschleger Eye Research Institute, Tel Aviv University Sackler Faculty of Medicine, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.
Sang-Jin SuhDepartment of Biomedical Sciences, Texas A&M College of Dentistry, Dallas, Texas, United States of America.
Dennis E OhmanDepartment of Microbiology and Immunology, Virginia Commonwealth University Medical Center, Richmond, Virginia, United States of America.
Efrat KesslerMaurice and Gabriela Goldschleger Eye Research Institute, Tel Aviv University Sackler Faculty of Medicine, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Israel.ORCID 0000-0003-2129-5437
Tel Aviv University · ILVirginia Commonwealth University Medical Center · US

Funding

GENETICS OF ALGINATE BIOSYNTHESIS IN P. AERUGINOSAR01AI019146 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI OHMAN, DENNIS EDWARD · 1985 to 2011
$2.7M
Activation of Alginate Genes in Pseudomonas aeruginosaR56AI019146 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI OHMAN, DENNIS EDWARD · 2006 to 2013
$682k
Pathogenic Mechanism for Lung Infection in Mucoid PseudomonasI01BX000477 · VA · VA VETERANS ADMINISTRATION HOSPITAL · PI OHMAN, DENNIS EDWARD, ZHOU, HUIPING · 2011 to 2025
–
BLRD VA I01 BX000477NIAID NIH HHS R01 AI019146NIAID NIH HHS R56 AI019146
6 · The paper itself

Abstract

Pseudomonas aeruginosa secretes several endopeptidases, including elastase, alkaline proteinase (Apr), a lysine-specific endopeptidase (LysC), and an aminopeptidase (PaAP), all of which are important virulence factors. Activation of the endopeptidases requires removal of an inhibitory N-terminal propeptide. Activation of pro-PaAP, in contrast, requires C-terminal processing. The activating proteases of pro-PaAP and their cleavage site(s) have not yet been defined. Studying pro-PaAP processing in a wild type P. aeruginosa strain and strains lacking either elastase or both elastase and Apr, we detected three processing variants, each ~56 kDa in size (AP56). Activity assays and N- and C-terminal sequence analyses of these variants pointed at LysC as the principal activating protease, cleaving a Lys512-Ala513 peptide bond at the C-terminal end of pro-PaAP. Elastase and/or Apr are required for activation of LysC, suggesting both are indirectly involved in activation of PaAP. To shed light on the function(s) of the N-terminal domain of AP56, we purified recombinant AP56 and generated from it the 28 kDa catalytic domain (AP28). The kinetic constants (Km and Kcat) for hydrolysis of Leu-, Lys-, Arg- and Met-p-nitroanilide (pNA) derivatives by AP56 and AP28 were then determined. The catalytic coefficients (Kcat/Km) for hydrolysis of all four substrates by AP28 and AP56 were comparable, indicating that the non-catalytic domain is not involved in hydrolysis of small substrates. It may, however, regulate hydrolysis of natural peptides/proteins. Lys-pNA was hydrolyzed 2 to 3-fold more rapidly than Leu-pNA and ~8-fold faster than Arg- or Met-pNA, indicating that Lys-pNA was the preferred substrate.

Indexed as

ProteolysisAmino Acid SequenceAminopeptidasesCatalytic DomainHydrolysisKineticsMetalloendopeptidasesPancreatic ElastaseProtein DomainsPseudomonas aeruginosaSubstrate SpecificityAminopeptidasesMetalloendopeptidasesPancreatic Elastasepeptidyl-Lys metalloendopeptidase

Identifiers

PMID34133429
PMCPMC8208579
OpenAlexW3170125341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.